Argent BioPharma Limited
RGT.L · LSE
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | £1 | £0 | £2 | £5 |
| Short-Term Investments | £0 | £0 | £0 | £0 |
| Receivables | £0 | £1 | £2 | £2 |
| Inventory | £1 | £1 | £2 | £1 |
| Other Curr. Assets | £1 | £0 | £1 | £1 |
| Total Curr. Assets | £3 | £3 | £6 | £9 |
| Property Plant & Equip (Net) | £7 | £7 | £9 | £7 |
| Goodwill | £0 | £0 | £3 | £7 |
| Intangibles | £0 | £0 | £0 | £0 |
| Long-Term Investments | £1 | £0 | £0 | £0 |
| Tax Assets | £0 | £0 | £0 | £0 |
| Other NC Assets | £0 | £0 | £0 | £1 |
| Total NC Assets | £8 | £7 | £12 | £15 |
| Other Assets | £0 | £0 | £0 | £0 |
| Total Assets | £11 | £10 | £19 | £24 |
| Liabilities | – | – | – | – |
| Payables | £1 | £2 | £3 | £1 |
| Short-Term Debt | £0 | £0 | £2 | £4 |
| Tax Payable | £0 | £0 | £0 | £0 |
| Deferred Revenue | £1 | £1 | £2 | £0 |
| Other Curr. Liab. | £10 | £10 | £1 | £1 |
| Total Curr. Liab. | £12 | £13 | £8 | £6 |
| LT Debt | £1 | £0 | £2 | £2 |
| Deferred Rev, NC | £4 | £4 | £4 | £3 |
| Deferred Tax Liab, NC | £0 | £0 | £0 | £0 |
| Other NC Liab. | £0 | £0 | £0 | £0 |
| Total NC Liab. | £4 | £5 | £6 | £4 |
| Other Liabilities | £0 | £0 | £0 | £0 |
| Cap. Leases | £1 | £1 | £2 | £2 |
| Total Liabilities | £17 | £18 | £13 | £10 |
| Equity | – | – | – | – |
| Pref Stock | £0 | £0 | £0 | £0 |
| Common Stock | £123 | £104 | £97 | £85 |
| Retained Earnings | -£130 | -£119 | -£98 | -£78 |
| AOCI | £1 | £8 | £7 | £7 |
| Other Equity | £1 | £0 | £0 | £0 |
| Total Equity | -£5 | -£7 | £6 | £14 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -£1 | -£1 | -£1 | -£0 |
| Total Liab. & Tot. Equity | £11 | £10 | £19 | £24 |
| Net Debt | £0 | £0 | £2 | £1 |